Reboxetine Treatment Reduces Neuroinflammation and Neurodegeneration in the 5xFAD Mouse Model of Alzheimer’s Disease: Role of CCL2

Alternative Method to Detect Neuronal Degeneration and Amyloid β Accumulation in Free-Floating Brain Sections With Fluoro-Jade

(2018) Irene L. Gutiérrez et al.   ASN Neuro

Reactive astrocytes in Alzheimer’s disease: A double-edged sword

(2018) Heejung Chun et al.   NEUROSCIENCE RESEARCH

Bindarit, Inhibitor of CCL2 Synthesis, Protects Neurons Against Amyloid-β-Induced Toxicity

(2018) Cinzia Severini et al.   JOURNAL OF ALZHEIMERS DISEASE

Increased tau phosphorylation follows impeded dopamine clearance in a P301L and novel P301L/COMT-deleted (DM) tau mouse model

(2018) J Koppel et al.   JOURNAL OF NEUROCHEMISTRY

Neuronal CCL2 expression drives inflammatory monocyte infiltration into the brain during acute virus infection

(2017) Charles L. Howe et al.   Journal of Neuroinflammation

The locus coeruleus neuroprotective drug vindeburnol normalizes behavior in the 5xFAD transgenic mouse model of Alzheimer’s disease

(2017) David Braun et al.   BRAIN RESEARCH

Cyclooxygenase inhibition targets neurons to prevent early behavioural decline in Alzheimer’s disease model mice

(2016) Nathaniel S. Woodling et al.   BRAIN

Presenilin-1 familial Alzheimer’s disease mutation alters hippocampal neurogenesis and memory function in CCL2 null mice

(2015) Tomomi Kiyota et al.   BRAIN BEHAVIOR AND IMMUNITY

Absence of CCL2 and CCL3 Ameliorates Central Nervous System Grey Matter But Not White Matter Demyelination in the Presence of an Intact Blood–Brain Barrier

(2015) Katharina Janssen et al.   MOLECULAR NEUROBIOLOGY

Noradrenergic dysfunction in Alzheimer's disease

(2015) Mary Gannon et al.   Frontiers in Neuroscience

Noradrenergic Regulation of Glial Activation: Molecular Mechanisms and Therapeutic Implications

(2014) David Braun et al.   Current Neuropharmacology

Dual effects of noradrenaline on astroglial production of chemokines and pro-inflammatory mediators

(2013) Ara E Hinojosa et al.   Journal of Neuroinflammation

A deficiency in CCR2+ monocytes: the hidden side of Alzheimer's disease

(2013) Gaëlle Naert et al.   Journal of Molecular Cell Biology

Targeting norepinephrine in mild cognitive impairment and Alzheimer's disease

(2013) Termpanit Chalermpalanupap et al.   Alzheimers Research & Therapy

Selective Loss of Noradrenaline Exacerbates Early Cognitive Dysfunction and Synaptic Deficits in APP/PS1 Mice

(2012) Thea Hammerschmidt et al.   BIOLOGICAL PSYCHIATRY

CCL2 affects β-amyloidosis and progressive neurocognitive dysfunction in a mouse model of Alzheimer's disease

(2012) Tomomi Kiyota et al.   NEUROBIOLOGY OF AGING

CCL2 Is Associated with a Faster Rate of Cognitive Decline during Early Stages of Alzheimer's Disease

(2012) Karin Westin et al.   PLoS One

The noradrenaline precursor L-DOPS reduces pathology in a mouse model of Alzheimer's disease

(2011) Sergey Kalinin et al.   NEUROBIOLOGY OF AGING

The Chemokine CCL2 Protects Against Methylmercury Neurotoxicity

(2011) David Godefroy et al.   TOXICOLOGICAL SCIENCES

MCP-1: Chemoattractant with a role beyond immunity: A review

(2010) Amita Yadav et al.   CLINICA CHIMICA ACTA

Role of CCL2 (MCP-1) in Traumatic Brain Injury (TBI): Evidence from Severe TBI Patients and CCL2−/− Mice

(2010) Bridgette D Semple et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Regulation of MCP-1 production in brain by stress and noradrenaline-modulating drugs

(2010) Jose L. M. Madrigal et al.   JOURNAL OF NEUROCHEMISTRY

Norepinephrine enhances the LPS-induced expression of COX-2 and secretion of PGE2 in primary rat microglia

(2010) Johannes CM Schlachetzki et al.   Journal of Neuroinflammation

Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine

(2010) M. T. Heneka et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Role of Chemokines in CNS Health and Pathology: A Focus on the CCL2/CCR2 and CXCL8/CXCR2 Networks

(2009) Bridgette D Semple et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Monocyte Chemoattractant Protein-1 (MCP-1): An Overview

(2009) Satish L. Deshmane et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

Astrocyte-Derived MCP-1 Mediates Neuroprotective Effects of Noradrenaline

(2009) J. L. M. Madrigal et al.   JOURNAL OF NEUROSCIENCE

CCL2 Accelerates Microglia-Mediated Aβ Oligomer Formation and Progression of Neurocognitive Dysfunction

(2009) Tomomi Kiyota et al.   PLoS One

Monocyte Chemoattractant Protein-1 Plays a Dominant Role in the Chronic Inflammation Observed in Alzheimer's Disease

(2008) Anna Sokolova et al.   BRAIN PATHOLOGY